Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation

Saved in:
Bibliographic Details
Published inClinical immunology (Orlando, Fla.) Vol. 173; pp. 147 - 148
Main Authors Koga, Tomohiro, Sato, Tomohito, Umeda, Masataka, Fukui, Shoichi, Horai, Yoshiro, Kawashiri, Shin-ya, Iwamoto, Naoki, Ichinose, Kunihiro, Nakamura, Hideki, Kawakami, Atsushi
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.12.2016
Subjects
Allergy and Immunology
Antirheumatic Agents - therapeutic use
Arthritis, Rheumatoid - complications
Arthritis, Rheumatoid - drug therapy
Female
Humans
Janus Kinase Inhibitors - therapeutic use
Middle Aged
Palmoplantar pustulosis
Piperidines - therapeutic use
Psoriasis - complications
Psoriasis - drug therapy
Pyrimidines - therapeutic use
Pyrroles - therapeutic use
Rheumatoid arthritis
Th1 cells
Th17-1 cells
Tofacitinib
Treatment Outcome
Th1 cells
Tofacitinib
Rheumatoid arthritis
Th17-1 cells
Palmoplantar pustulosis
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1521-6616
1521-7035
DOI:10.1016/j.clim.2016.10.003